Objective: To appreciate the impact of the opioid epidemic in workers, we described opioid prescription patterns in a US industrial cohort over a 10-year period and assessed predictors of chronic prescription. Methods: A A multiyear (2003 to 2013) cross-sectional analysis of employer-sponsored health care claims for enrolled workers (N: 21,357 to 44,769) was performed. Results: The proportion of workers prescribed opioids nearly doubled in the 10-year period. The strongest predictor of chronic opioid prescribing was year, with an increase in prescriptions each year from 2003 to 2013 (odds ratio ¼ 2.90, 95% confidence interval: 2.41 to 3.48). Additional predictors included older age, white race, hourly wage, low back pain, and osteoarthritis. Conclusions: Opioid prescribing for industrial workers substantially increased from 2003 to 2013. Occupational health professionals should be aware of the potential for chronic opioid use among workers to assess job safety and appropriate treatment of work-related injuries.
I
n the last 15 years, there has been an epidemic of opioid prescribing, opioid abuse, overdose, and overdose deaths in the United States. 1, 2 The opioid epidemic is a major health problem affecting all people, but poses unique concerns for working individuals.
Industrial workers are susceptible to acute occupational and repetitive strain injuries. 3 The aging workforce has increasingly been prescribed opioids for chronic pain conditions such as arthritis since 1999. 1 Most estimates of opioid prescriptions in workers come from Worker's Compensation claims, and estimates of opioid prescribing within 15 days of a work-related injury range from 6% to 53%, 4 depending on the geographic region and severity of the injury. Early opioid prescription for acute work-related low back pain is associated with increased worker disability, higher medical costs, prolonged claim duration, and lower work retention. [5] [6] [7] [8] Few studies have assessed the predictors of opioid prescribing among industrial workers. 9 Data to support the prescription of opioids for chronic pain reduction or functional improvement are lacking, [10] [11] [12] and chronic opioid use increases the risk of opioid abuse, overdose, fracture, and adverse cardiac outcomes. 11, 13, 14 A recent large claims-based cohort study determined that 0.5% of injured workers prescribed opioids are diagnosed with opioid use disorder within 12 months of injury. 15 Workers diagnosed with opioid use disorder pose a much greater economic burden on the healthcare system, and workers on short-term disability with diagnosed opioid abuse have significantly greater lost wages and time away from work than those without a diagnosis of opioid use disorder. 15 The excess employer and societal costs related to opioid abuse are substantial. A 2011 cost analysis determined total yearly employer costs for opioid abuse to be greater than $25 billion in 2007 US dollars irrespective of healthcare costs, which also totaled $25 billion. Lost work time, wages, and premature death made up the bulk of the employer-related costs. 16 A more recent cost analysis determined employer-related excess health care costs and lost wage costs per employee with diagnosed opioid abuse to be close to $12,000 US dollars annually. 17 Assessing the burden and consequences of opioid prescribing in workers poses a unique challenge due to the siloed nature of Occupational Health and the Worker's Compensation System. Workers may obtain prescriptions outside of the Workers' Compensation system for pain that may or may not be related to a workplace injury. 18 There is potential risk of opioid misuse if workers are filling prescriptions using multiple payment sources, such as private insurance and Workers' Compensation. 19 Another challenge is that clinicians outside of Occupational Health may have limited training in assessing workplace hazards. The American College of Occupational and Environmental Medicine recommends against the prescription of opioids for acute or chronic pain in safety-sensitive jobs. 20 However, not all prescribers may be familiar with a patient's occupational history, including work tasks, exposures, and safety risks.
In summary, industrial workers prescribed opioids may be at increased risk for injury, opioid misuse, and opioid use disorder. The objectives of this study are (1) to describe prescription patterns of opioids in an industrial cohort from employer-sponsored health insurance, which would represent prescriptions not covered by Worker's Compensation, and (2) to describe predictors of chronic opioid use in an industrial cohort.
METHODS
In this multiyear cross-sectional study, we analyzed employersponsored health claims from 76,432 industrial workers from the years 2003 through 2013. To be eligible for study inclusion, workers needed to have 3 consecutive months of enrollment in the employersponsored health plan during any given year. In each year, over 80% of workers elected health benefits. The number of employees analyzed each year ranged from 22,714 to 44,704. The population of workers decreased over the course of the study period largely due to recessionrelated plant closures.
We obtained claims data on an industrial cohort from a specialty metals corporation with multiple manufacturing facilities geographically dispersed throughout the United States. Data analysis occurred between October of 2016 and June of 2017. We assessed opioid prescription frequency during each year from January to December, and did not attempt to track individuals through time. Any of the following medications were classified as opioids: oxycodone, hydrocodone, codeine, morphine, fentanyl, hydromorphone, tramadol, meperidine, methadone, buprenorphine, Demerol, and propoxyphene. Antitussive syrups and liquids, migraine relief medications, and antiemetic and antidiarrheal medications containing opioid medications were not classified as opioids for the purposes of this study. Long-term opioid therapy is defined as daily or near daily use of opioids over the course of 90 days or more. 21 Prescription pharmacy claims provide number of days supplied, however, this is a frequent underestimate of the intended days' supply in the case of opioid therapy, as pharmacists calculate this number using the maximum amount of medications a patient could take in 24 hours. 22 Therefore, we defined chronic, or long-term, opioid prescription as the prescription of three or more consecutive opioids with a period of no more than 30 days between prescriptions, as has been done studies that utilize pharmacy claims data. 23, 24 We assessed the proportion of workers receiving one or more opioid prescriptions each year as well as the proportion of workers being prescribed opioids chronically each year during the study period. We also assessed the proportion of workers who were diagnosed with opioid use disorder (ICD-9 304.00, 304.01, 304.02, 304.03, 965.00, 965.09). To assess factors associated with chronic opioid use among those receiving opioid prescriptions, we analyzed employee-sponsored health claims data during each year of the study period. We assessed the relationship between chronic opioid prescriptions and opioid use disorder and age, sex, race, wage type, geographic region, and comorbid conditions including psychiatric conditions, low back pain, other back and neck pain, neuropathic pain, and osteoarthritis. Comorbid conditions were identified using International Classification of Diseases, Volume 2, Clinical Modification (ICD-9-CM) codes (see Table, Supplemental Digital Content 1, http://links.lww.com/JOM/A396, for the code listing).
Statistics/Data Analysis
Statistical analyses were performed using SAS Version 9.4 (SAS Institute, Cary, NC). Descriptive statistics were calculated for the start and end year of the study (2003 and 2013, respectively) for the total eligible population and for the cohort of workers receiving at least one opioid prescription. Among those receiving one or more opioid prescriptions in a calendar year, unadjusted analyses were used to examine potential associations between demographic factors (age, sex, race/ethnicity, employee type, geographic region), comorbid medical conditions, calendar year, and chronic opioid use. We then developed multivariate marginal (population-average) generalized linear models using generalized estimating equations (GEE) to determine predictors of chronic opioid use (Yes/No) among the cohort receiving any opioid prescriptions. All P-values were two sided and a < 0.05 was considered statistically significant. Table 1 (Table 1) . Over three quarters of workers were white, 21% were female, and 67% received an hourly wage. The proportion of workers diagnosed with depression, anxiety, low back pain, other back and neck pain, osteoarthritis, and diabetes increased over the 10-year period.
RESULTS
There was a substantial increase in opioid prescriptions with 10.5% of workers receiving one or more prescriptions in 2003 compared with 18.7% in 2013. Compared with their percentage contribution to the total population, women, hourly workers, and workers in the South comprised a greater percentage of those receiving opioids. Workers receiving one or more opioid prescription in each year were also more likely to have comorbid medical conditions ( Table 1) . Figure 1 illustrates the rise in prescribed opioids, chronic opioid use, and diagnoses of opioid use disorder over the 10-year study period. The increase in opioid prescriptions was statistically significant (P < 0.0001). There was also a statistically significant increase in chronic opioid prescriptions among workers 0.69% (n ¼ 310) in 2003 compared with 2.9% (n ¼ 681) in 2013 (P < 0.0001). The proportion of workers diagnosed with opioid use disorder increased more than 10-fold from 2003 (n ¼ 11, 0.02%) to 2013 (n ¼ 67, 0.28%), P < 0.0001 (Fig. 1) . In addition, the proportion of workers prescribed opioids chronically among those prescribed any opioids in a given year nearly tripled in the 10-year period (6.6% in 2003 compared with 16.0% in 2013) (Fig. 2) .
Before adjusting for potential confounding factors among those ever-prescribed opioids, older age workers, whites, hourly workers, and workers in facilities outside of the Northeast had higher odds of being prescribed opioids chronically (Table 2) . Workers with a diagnosis of depression/anxiety, low back pain, other back and neck pain, neuropathic pain, headache, osteoarthritis, and diabetes all had higher odds of being prescribed opioids chronically (Table 2) . Year was also strongly associated with chronic opioid prescription, with workers having more than a 3-fold odds of being prescribed opioids chronically in 2013 compared with 2003 (OR ¼ 3.23, 95% CI: 2.63 to 3.96).
After adjusting for age, sex, race, wage type, geographic region, and comorbid conditions, significant predictors of chronic opioid prescriptions included age, male sex, white race, hourly wage, geographic region outside the Northeast, comorbid pain and psychiatric conditions, and year. The odds of receiving opioids 
DISCUSSION
Ours is the first study of which we are aware to describe the prevalence of opioid prescriptions among a working cohort in the span of opioid epidemic. The prevalence of non-Worker's Compensation opioid prescriptions increased each year from 2003 to 2013 in this privately insured national industrial cohort. The diagnosis of opioid use disorder increased 10-fold over the 10-year period. Older age, white, and hourly workers were more likely to receive chronic opioid prescriptions. While female workers were more likely to receive opioids, men were more likely to receive opioids chronically. Workers outside of the Northeast were also more likely to receive opioid prescriptions chronically. Comorbid behavioral health conditions and multiple pain conditions including low back pain and osteoarthritis were associated with chronic opioid prescription. When controlling for demographic factors and comorbid conditions, year remained the strongest predictor of chronic opioid prescriptions, with a steady increase in the odds of chronic opioid prescription over the 10-year period. Opioid prescribing leveled off nationally in 2010 and began to taper in 2012, 1 however, in this study, we found a steady increase in opioid prescriptions and chronic prescribing through 2013.
There were recession-related plant closures over the study period, which would result in job loss. Each year, we described an employed and privately insured cohort. Unemployed and uninsured individuals are more likely to misuse opioids and more likely to be diagnosed with opioid use disorder. 13 This working cohort, however, may have experienced recession-related financial stress. Psychologic distress has been associated with longer duration of opioid prescription for low back pain, a common diagnosis among industrial workers. 25 A recent national survey demonstrated that 38% of American adults, and 35% of those who were employed full-time received an opioid prescription in 2015, 13 which is a much greater proportion than we found in our population. We described the majority (80% to 87%) of the working population who elected employer-sponsored private insurance, and do not know the insurance status of the remaining 13% to 20% of the workforce. Results from the national survey demonstrated that individuals receiving Medicaid benefits had a higher prevalence of opioid prescriptions, while those who were uninsured had a lower proportion of opioid prescriptions. It is unlikely that our results would change differentially if we were able to describe the full working population. The cross-sectional study found similar predictors of opioid use as found in our study such as older age, non-Hispanic white race, and lack of college education. Males were also more likely to meet criteria for misuse. 13 The difference in opioid prescription prevalence is likely partially explained by an underestimate of opioid use in our study.
Our study is limited in that we have relied on employersponsored health claims data to estimate opioid use. We did not have record of Workers' Compensation claims or an estimate of recreational drug use. According to a recent survey, 16.1% of workers aged 18 to 25 and 6.5% of workers aged 26 and older participate in non-medical use of prescription pain relievers. 26 In addition, we analyzed each year in cross-sections, and therefore, may have misclassified some chronic prescriptions as non-chronic. Our study, therefore, likely underestimates the prevalence of chronic opioid use among workers. Strengths of our study include the large size of the cohort and the geographic span of the population, which increases the generalizability of our findings. We also provide a view of nonWorkers' Compensation prescription claims for a working population, which is an aspect often overlooked. We demonstrated that workers, while generally healthier than the total population, 27 are also susceptible to the epidemic of opioid prescribing. Potential risks of chronic opioid prescribing that is unique to workers includes lost work time and disability. 5, 7, 8, 15 Our study is limited that we were not able to estimate dose or strength of prescription, which would give a better perception of complication risk.
Opioid prescribing for industrial workers by private clinicians increased substantially from 2003 to 2013. Occupational medicine clinicians should not only consider risk factors for misuse when prescribing opioids, but should also consider occupational hazards. Opioids should not be prescribed in workers operating vehicles or heavy machinery or in those whose jobs are highly cognitive. 20 Workers may obtain prescription opioids from multiple sources including private clinicians, and therefore occupational health providers should reference prescription monitoring programs.
